Intact Memory in TGF-β1 Transgenic Mice Featuring Chronic Cerebrovascular Deficit: Recovery with Pioglitazone
Open Access
- 23 June 2010
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 31 (1) , 200-211
Abstract
The roles of chronic brain hypoperfusion and transforming growth factor-beta 1 (TGF-β1) in Alzheimer's disease (AD) are unresolved. We investigated the interplay between TGF-β1, cerebrovascular function, and cognition using transgenic TGF mice featuring astrocytic TGF-β1 overexpression. We further assessed the impact of short, late therapy in elderly animals with the antioxidant N-acetyl–cysteine (NAC) or the peroxisome proliferator-activated receptor-γ agonist pioglitazone. The latter was also administered to pups as a prophylactic 1-year treatment. Elderly TGF mice featured cerebrovascular dysfunction that was not remedied with NAC. In contrast, pioglitazone prevented or reversed this deficit, and rescued the impaired neurovascular coupling response to whisker stimulation, although it failed to normalize the vascular structure. In aged TGF mice, neuronal and cognitive indices—the stimulus-evoked neurometabolic response, cortical cholinergic innervation, and spatial memory in the Morris water maze—were intact. Our findings show that impaired brain hemodynamics and cerebrovascular function are not accompanied by memory impairment in this model. Conceivably in AD, they constitute aggravating factors against a background of aging and underlying pathology. Our data further highlight the ability of pioglitazone to protect the cerebrovasculature marked by TGF-β1 increase, aging, fibrosis, and antioxidant resistance, thus of high relevance for AD patients.Keywords
This publication has 41 references indexed in Scilit:
- Effects of antihypertensive treatment on small artery remodellingJournal Of Hypertension, 2009
- The cognitive and histopathological effects of chronic 4-vessel occlusion in rats depend on the set of vessels occluded and the age of the animalsBehavioural Brain Research, 2009
- Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathologyNature Medicine, 2008
- Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic miceBiomedicine & Pharmacotherapy, 2008
- Astrocyte Control of Synaptic Transmission and Neurovascular CouplingPhysiological Reviews, 2006
- Microsphere embolism‐induced cortical cholinergic deafferentation and impairments in attentional performanceEuropean Journal of Neuroscience, 2005
- Cerebrovascular Transforming Growth Factor-β Contributes to Inflammation in the Alzheimer’s Disease BrainThe American Journal of Pathology, 2002
- Cerebral microvascular pathology in aging and Alzheimer's diseaseProgress in Neurobiology, 2001
- Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's diseaseNeuroscience, 1999
- SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor proteinNature Neuroscience, 1999